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There was no correlation between the
rates at which the tumours were proliferating
and cellular immune competence.
CELL MEDIATED IMMUNITY IN
CHILDHOOD TUMOURS, S. Kumar,
Christie Hospital, Manchester.
Lymphocytotoxicity tests using the
Hellstr6ms' technique were carried out to
study cell mediated and humoral immunity
in several histological types of childhood
tumour. Tumour type specific lymphocyte
reactivity was detected in most of these
patients; lymphocytes from children Mwith
renal tumours showed a significant cross
reactivity. The degree of lymphocyte
mediated tumour cell killing appeared to be
independent ofthe stage of progression ofthe
tumour. Sera from children with clinically
active tumours blocked the lymphocyto-
toxicity.
A NEW LOOK AT THE EB VIRUS AND
ONCOGENESIS, R. N. P. Sutton, Depart-
ment ofMicrobiology, King's College Hospital
Medical School, London.
The EB virus, a herpes-like DNA virus,
has been associated with malignant disease
(Burkitt's lymphoma, nasopharyngeal carci-
noma) and with infectious mononucleosis and
asymptomatic infections. Spiegelman and
his colleagues (Proc. natn. Acad. Sci. U.S.A.,
1973, 70, 5) have recently detected nucleic
acid homologous with that of the RNA
Rauscher murine leukaemia virus in Burkitt's
lymphoma and nasopharyngeal carcinoma
cells.
This apparent conflict may be resolved
bythe assumption that the temporary depres-
sion of cell mediated immunity which occurs
with EB infection in infectious mono-
nucleosis also occurs in asymptomatic infec-
tions and is the necessary stimulus which
activates an otherwise dormant RNA virus
genome.
Sixty-eight children with acute lympho-
blastic leukaemia were tested for antibodies
to commonly encountered viruses, including
the EB virus; their antibody responses were
normal, indicating intact humoral immunity.
In the case of the EB virus, the antibody
pattern in children tested during the first
month of their leukaemic illness suggested
that a high proportion had experienced
infection with this virus. In view of the
potential immunosuppressive properties of
the EB virus, it is suggested that these
findings mav be related to the leukaemogenic
process.
INDEPENDENT RESPONSES OF
DIFFERENT BINDING SITES ON
EHRLICH ASCITES TUMOUR CELLS
TO TRYPSIN AND TRYPSIN IN-
HIBITOR, P. Whur, Noreen E. Payne and
H. Koppel, The Marie Curie Memorial
Foundation, Oxted.
We previously reported (Whur, Robson
and Payne, Br. J. Cancer, 1973, 28, 80) that
Ehilich ascites tumour cells do not adhere to
mouse host intraperitoneal surfaces unless
treated wvith soybean trypsin inhibitor.
We have subsequently found that the
binding of these cells to NCTC clone 929
mouse cell monolayers in vitro is significantly
enhanced in the presence oftrypsin inhibitor.
However, under the same conditions, adhesion
to plastic surfaces is inhibited by trypsin
inhibitor. Furthermore, incubationoftumour
cells in very low concentrations of trypsin
significantly enhances their adhesion to
plastic surfaces.
These findings suggest that the degree to
wrhich binding sites are expressed is altered by
increasing or decreasing proteolysis of cell
surface components, and that altered proteo-
lysis may suppress the expression of one site
while simultaneously enhancing another.
ULTRASTRUCTURAL AND BIO-
CHEMICAL STUDIES OF THE
EFFECTS OF CONCANAVALIN A ON
LANDSCHUTZ ASCITES TUMOUR
(LAT) CELLS, R. G. P. Pugh-Humphreys
and D. Lawson, Department of Zoology,
University of Aberdeen.
Concanavalin A, a protein which binds
terminal non-reducing o-methyl-D-manno-
pyranosides and o-methyl-D-glucopyrano-
sides (Goldstein, Lucy and Yang, J. Immun.,
1969, 103, 695), agglutinates and induces
functional changes in a variety of cells
(Sharon and Lis, Science, N.Y., 1972, 177,
949) and is cytotoxic to ascites tumour cells
(Inbar, Ben-Basset and Saclis, Int. J. Cancer,
1972, 9, 143).
Concanavalin A treatment of LAT cells
resulted in marked cell agglutination, stimu-
lated 02 uptake and pinocytotic activity
(including pinocytosis of concanavalin A),